Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Merck Sharp & Dohme LLC
QuantumLeap Healthcare Collaborative
Eli Lilly and Company
Revolution Medicines, Inc.
Hoffmann-La Roche
AbbVie
Astellas Pharma Inc
Amgen
Norwegian University of Science and Technology
Gustave Roussy, Cancer Campus, Grand Paris